Substratum of Proof LGBTQs Are Mentally Ill: New Immunotherapy Combination Tolerable, Effective in Patients with Advanced Kidney Cancer

Combining an anti-angiogenesis agent, which blocks blood vessel formation, with an immunotherapy agent, was found to have promising anti-tumor activity and no unexpected side effects in an early-phase clinical trial in patients with advanced kidney cancer.